priority health glp-1 coverage The evolving landscape of anti-obesity medication in Medicaid New GLP-1 Solution with Vida

& Yutzey, K

Studies in growth hormone-deficient mice show that while other growth hormone secretagogues increased body fat through growth hormone-independent mechanisms that included increased feeding, ipamorelin's effects on body composition are primarily mediated through its growth hormone-releasing properties

Diabetes 50 , 22372243 (2001)

This calming effect on brain activity also influences pathways related to cravings, which is why researchers are studying Topamax for potential use in treating alcohol use disorder and other addictions

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme

It ruled that three of the plaintiffs experts used sufficiently reliable methods to present their opinions in court